Other Gynecological Cancers

Under this section, we discuss integrative management of much rarer gynecological cases that occur in vulva, vagina and fallopian tube.

CASE 1 - MDM VNM – 42 Yrs (PRIMARY VAGINAL CANCER)

Mdm. VNM was 42 years old when she was diagnosed with vaginal cancer. She was an extremely anxious mother of 3 children. She had suffered from endometriosis and uterine fibroids. At the age of 41 she had undergone a hysterectomy (with ovarian conservation) for intractable pain and heavy periods.

One year after the surgery she had a growth at the vaginal vault and mid portion of the posterior vaginal wall. A biopsy confirmed this to be a moderately differentiated squamous cell cancer. She was advised by her oncologist to choose between 1. Total vaginectomy and chemotherapy and 2. Chemotherapy with radiation treatment. She was devastated as both options would destroy her femininity and sexual life.

She came to the Healing Zone (ICCM) to consider other “more palatable” options.

She underwent an excision of the tumor followed by the following therapies: metabolic, HDIVC, Laetrile and vaginal ozone.

She responded very well, and the wound and cancer healed beautifully leaving a normal vaginal intact.

She has remained cancer free for almost 7 years.

Discussion Primary vaginal cancer is a rare cancer, mainly in the older woman. The usual treatments would destroy much of the pelvic anatomy and preclude normal sexual function. Mdm. VNM benefited from the healing-based treatment and minimal surgery thereby preserving normal anatomy and function.

CASE 2 – MRS. NK – PAGET’S DISEASE OF VULVA

Mrs NK was a 76-year-old Sikh Lady who had a Paget^’s disease of the vulva. She had a daughter who was senior medical practitioner. She has been diabetic and hypertensive for more than 20 years.

She initially presented with a history of PRURITUS and subsequently bleeding from the vulva. She had her biopsy done at UMMC and this confirmed Paget's disease of the vulva. At the time of the diagnosis the lesions covered most of the vulva on both sides but particularly is more severe on the right side.

She was advised to undergo radical vulvectomy and lymph node removal from the groins to be followed by chemotherapy and radiotherapy. However, due to her knowledge of the possible complications that can arise from both the surgery and subsequent chemo radiation she had sought a second opinion.

In the healing zone we discussed a conservative management using a metabolic based therapy and the use of high dose intravenous vitamin C, B17 and other antioxidant supports. She was quite keen to give this a try as a first line and to keep her options open for surgery and chemo radiation if the treatment did not help.

This patient responded extremely well and within three months of treatment her lesions had almost completely vanished leaving just one small focus on the right labia of the vulva measuring less than 1 cm at this point. At this point she was offered a modified surgical procedure. She underwent wide local excision of this residual lesion, and she made an excellent recovery with very minimal functional impairment.

She has been followed up for almost 4 years now and has remained cancer free and leads a normal and full life.

DISCUSSION Paget’s disease of the vulva is a very rare condition, and it is usually managed in conventional oncology with a combination of surgery, chemotherapy and radiotherapy. This patient was fully aware of the debilitating side-effects of such a treatment. Radical vulvectomy is a rather disfiguring surgery and often leads to marked impairment of function as well as loss of self-esteem and confidence because of the radical nature of the surgery. This patient knowingly took a different course of action and fortunately for her that the healing-based therapies have helped her overcome this rare cancer.